Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: Relation of Epicardial Fat and Diabetic Nephropathy in Egyptian Patients
A clinical trial update from Assiut University examining how epicardial fat relates to diabetic nephropathy in people with type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update for GW823093 in Japanese adults with Type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Whole Grains, Gastric Emptying and Glycemic Response [NA]
This update reports on a completed Purdue University clinical trial evaluating the effects of whole grains on gastric emptying and glycemic …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Improving Risk Factors for Diabetes Complications in Primary Care [NA]
A completed primary-care clinical trial focused on improving risk factors related to diabetes complications in adults with Type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Smartphone Application for Type 2 Diabetes [NA]
A clinical trial update notes the completion of a smartphone application intervention study for Type 2 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-03-16FDA Approved: METFORMIN ER 500 MG — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved Quallent Pharmaceuticals Health LLC's metformin extended-release tablets (500 mg and 750 mg) under ANDA 209313 for type 2 diabe…
-
CLINICAL_TRIALS research · 2018-03-15Clinical Trial Update: Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating cardiovascular and other long-term outcomes with semaglutide in adults with type 2 diabetes has completed, with r…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients [NA]
A completed clinical trial evaluating whether Vitamin B12 supplementation improves glycemic control in patients with Type 2 diabetes and hyp…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849) [Phase 3]
A long-term Phase 3 trial evaluating ipragliflozin added to sitagliptin in Japanese participants with type 2 diabetes mellitus has completed…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects [Phase 4]
Phase 4 extension study update for albiglutide in type 2 diabetes to assess long-term safety, tolerability, and pharmacodynamics; study term…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A New Oral Treatment For Type II Diabetes Mellitus [Phase 2]
Phase 2 trial of a new oral treatment for Type 2 diabetes mellitus completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study [NA]
A pilot study evaluating brief cognitive-behavioral therapy interventions delivered by nurse care managers to improve outcomes in adults wit…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Study of LY2189102 in Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for LY2189102 in type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India
Post-marketing surveillance study updating the safety and usage of Ryzodeg (insulin degludec/insulin aspart) in diabetes patients in routine…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Smart Glucose Meter Project [NA]
Clinical trial update for a smart glucose meter project; the study was terminated and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing insulin to insulin glargine in adults with Type 2 diabetes has completed, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Mechanisms of Diabetes Control After Weight Loss Surgery
Clinical trial update on the mechanisms by which weight loss surgery improves diabetes control in obese patients.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing two insulin dosing algorithms in insulin-naive patients with type 2 diabetes; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2018-03-09Clinical Trial Update: Assessment of a Health Informatics System on Insulin-treated Diabetic Patients
The clinical trial evaluating a health informatics system for insulin-treated patients with type 1 or type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing weekly semaglutide to daily insulin glargine as add-on to metformin (with or without sulphonylurea) in insulin-naï…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004) [Phase 2]
A Phase 2 trial investigating MK-8521 for Type 2 Diabetes Mellitus was terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of a SGLT2 inhibitor or a DPP-4 inhibitor in adults with type 2 diabetes mellitus trea…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care
Prospective primary care study evaluating cardiovascular risk factors in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843) [Phase 3]
Phase 3 double-blind trial evaluating ipragliflozin add-on to sitagliptin in Japanese adults with type 2 diabetes poorly controlled on sitag…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes [Phase 1]
A Phase 1 clinical trial evaluated the effects of semaglutide on beta-cell function in subjects with Type 2 Diabetes Mellitus; the study has…